BioSpace News Archive

Vertex to Present at the Bank of America Securities 2021 Virtual Health Care Conference on May 13

Bigfoot Biomedical ® Receives FDA Clearance for Bigfoot Unity ™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes Integrated with Abbott’s FreeStyle ® Libre 2 system, the Bigfoot Unity System is the first and only to translate continuously monitored glucose data into on-demand insulin dose recommendations displayed right on the pen-cap screen for ease of use 1

SkyTeam currently has 19 members and operates more than 15,445 flights each day to 1,036 cities in over 170 countries across the world. SkyTeam members are dedicated to delivering their passengers with safe, reliable, and comfortable journeys.

This facility will span across 2.200m2 with multiple ISO7 clean rooms intended for the manufacturing of silicone tubing,thermoplastic tubing, bioprocessing bags and the integration of single use fluid transfer systems.

Vivet Therapeutics today announced that new data regarding VTX-803, Vivet’s AAV-based gene therapy in development for the treatment of PFIC3, will be presented during the ASGCT 24th Annual Meeting, May 11 - 14, 2021.

Headquarters in CIC Philadelphia shared workspace will facilitate networking with local biotech leaders and potential pharma and academic collaborators

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced acceptance of an abstract for KVD900 as an oral presentation at the 12th C1-Inhibitor Deficiency & Angioedema Workshop, which will be held virtually from June 3-6, 2021.

Centessa Pharmaceuticals announced that Antoine Yver, M.D., M.Sc., has been appointed as Chief Medical Officer.

Attralus, backed by venBio Partners, recruits new leadership team to support advancement of its pipeline to bring transformational pan-amyloid removal therapies to the systemic amyloidosis field

Preclinical data provide quantitative evidence of miRARE’s ability to exhibit genotype-dependent regulation of MECP2 gene expression across different brain regions in both wild type and knockout mouse models of Rett syndrome